{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:11:28Z","timestamp":1788768688765,"version":"build-2803163510"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12015-026-11187-5","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:28:27Z","timestamp":1784089707000},"page":"3104-3116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial Blood and Stem Cell\u2013Derived Oxygen Therapeutics in Oncology: Emerging Strategies for Overcoming Tumor Hypoxia"],"prefix":"10.1007","volume":"22","author":[{"given":"Kamini","family":"Shivhare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Shadab","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"1","key":"11187_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10238-024-01501-1","volume":"24","author":"J Ciep\u0142a","year":"2024","unstructured":"Ciep\u0142a, J., & Smolarczyk, R. (2024). Tumor hypoxia unveiled: Insights into microenvironment, detection tools and emerging therapies. Clinical and experimental medicine, 24(1), 235.","journal-title":"Clinical and experimental medicine"},{"issue":"3","key":"11187_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s12276-024-01180-8","volume":"56","author":"T Bae","year":"2024","unstructured":"Bae, T., Hallis, S. P., & Kwak, M-K. (2024). Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer. Experimental & molecular medicine, 56(3), 501\u2013514.","journal-title":"Experimental & molecular medicine"},{"key":"11187_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217913","author":"C Wu","year":"2025","unstructured":"Wu, C., Xu, T., Zhang, H., Hu, Y., Jiao, J., Qiu, K., et al. (2025). Hypoxia and immunometabolism in the tumor microenvironment: Insights into mechanisms and therapeutic potential. Cancer Letters. 631,217913. https:\/\/doi.org\/10.1016\/j.canlet.2025.217913","journal-title":"Cancer Letters"},{"issue":"4","key":"11187_CR4","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.3390\/ijms25042060","volume":"25","author":"S Musleh Ud Din","year":"2024","unstructured":"Musleh Ud Din, S., Streit, S. G., Huynh, B. T., Hana, C., Abraham, A-N., & Hussein, A. (2024). Therapeutic targeting of hypoxia-inducible factors in cancer. International journal of molecular sciences, 25(4), 2060.","journal-title":"International journal of molecular sciences"},{"issue":"1","key":"11187_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-022-01080-1","volume":"7","author":"Z Luo","year":"2022","unstructured":"Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., et al. (2022). Hypoxia signaling in human health and diseases: Implications and prospects for therapeutics. Signal transduction and targeted therapy, 7(1), 218.","journal-title":"Signal transduction and targeted therapy"},{"issue":"2","key":"11187_CR6","first-page":"51","volume":"80","author":"JE Ziello","year":"2007","unstructured":"Ziello, J. E., Jovin, I. S., & Huang, Y. (2007). Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. The Yale journal of biology and medicine, 80(2), 51.","journal-title":"The Yale journal of biology and medicine"},{"issue":"1","key":"11187_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-4598-14-4","volume":"14","author":"C Fischer","year":"2015","unstructured":"Fischer, C., Leithner, K., Wohlkoenig, C., Quehenberger, F., Bertsch, A., Olschewski, A., et al. (2015). Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1\u03b1 destabilization. Molecular cancer, 14(1), 4.","journal-title":"Molecular cancer"},{"issue":"12","key":"11187_CR8","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1038\/aps.2017.79","volume":"38","author":"J-q Li","year":"2017","unstructured":"Li, J.-q, Wu, X., Gan, L., Yang, X.-l, & Miao, Z.-h. (2017). Hypoxia induces universal but differential drug resistance and impairs anticancer mechanisms of 5-fluorouracil in hepatoma cells. Acta Pharmacologica Sinica, 38(12), 1642\u201354.","journal-title":"Acta Pharmacologica Sinica"},{"key":"11187_CR9","doi-asserted-by":"publisher","first-page":"110623","DOI":"10.1016\/j.biopha.2020.110623","volume":"130","author":"X Sun","year":"2020","unstructured":"Sun, X., Lv, X., Yan, Y., Zhao, Y., Ma, R., He, M., et al. (2020). Hypoxia-mediated cancer stem cell resistance and targeted therapy. Biomedicine & Pharmacotherapy, 130, 110623.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"11187_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12951-024-03060-9","volume":"23","author":"N Mohanto","year":"2025","unstructured":"Mohanto, N., Mondal, H., Park, Y-J., & Jee, J-P. (2025). Therapeutic delivery of oxygen using artificial oxygen carriers demonstrates the possibility of treating a wide range of diseases. Journal of nanobiotechnology, 23(1), 25.","journal-title":"Journal of nanobiotechnology"},{"key":"11187_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biomaterials.2018.08.004","volume":"182","author":"J Yang","year":"2018","unstructured":"Yang, J., Li, W., Luo, L., Jiang, M., Zhu, C., Qin, B., et al. (2018). Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance. Biomaterials, 182, 145\u2013156.","journal-title":"Biomaterials"},{"issue":"18","key":"11187_CR12","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.1158\/0008-5472.CAN-20-1049","volume":"80","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Chen, Y., Bao, L., Zhang, B., Wang, J. E., Kumar, A., et al. (2020). CHD4 promotes breast cancer progression as a coactivator of hypoxia-inducible factors. Cancer research, 80(18), 3880\u20133891.","journal-title":"Cancer research"},{"issue":"52","key":"11187_CR13","doi-asserted-by":"publisher","first-page":"33835","DOI":"10.1039\/D2RA06036A","volume":"12","author":"SA Salim","year":"2022","unstructured":"Salim, S. A., Salaheldin, T. A., Elmazar, M. M., Abdel-Aziz, A., & Kamoun, E. A. (2022). Smart biomaterials for enhancing cancer therapy by overcoming tumor hypoxia: A review. RSC advances, 12(52), 33835\u201333851.","journal-title":"RSC advances"},{"issue":"4","key":"11187_CR14","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s11517-024-03233-6","volume":"63","author":"R Sharma","year":"2025","unstructured":"Sharma, R., Kashyap, M., Zayed, H., Krishnia, L., & Kashyap, M. K. (2025). Artificial blood\u2014hope and the challenges to combat tumor hypoxia for anti-cancer therapy. Medical & Biological Engineering & Computing, 63(4), 933\u2013957.","journal-title":"Medical & Biological Engineering & Computing"},{"issue":"3","key":"11187_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101017","volume":"14","author":"VL Codony","year":"2021","unstructured":"Codony, V. L., & Tavassoli, M. (2021). Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancer. Translational Oncology, 14(3), Article 101017.","journal-title":"Translational Oncology"},{"issue":"5","key":"11187_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/10731190802369789","volume":"36","author":"J Han","year":"2008","unstructured":"Han, J., Yu, M., Dai, M., Cui, P., Li, H., Zhang, J., et al. (2008). Effect of artificial oxygen carrier with chemotherapy on tumor hypoxia and neovascularization. Artificial cells blood substitutes and biotechnology, 36(5), 431\u2013438.","journal-title":"Artificial cells blood substitutes and biotechnology"},{"issue":"8","key":"11187_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ctrv.2007.08.002","volume":"33","author":"M Yu","year":"2007","unstructured":"Yu, M., Dai, M., Liu, Q., & Xiu, R. (2007). Oxygen carriers and cancer chemo-and radiotherapy sensitization: Bench to bedside and back. Cancer treatment reviews, 33(8), 757\u2013761.","journal-title":"Cancer treatment reviews"},{"issue":"13","key":"11187_CR18","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1177\/1535370220934038","volume":"245","author":"S Roy","year":"2020","unstructured":"Roy, S., Kumaravel, S., Sharma, A., Duran, C. L., Bayless, K. J., & Chakraborty, S. (2020). Hypoxic tumor microenvironment: Implications for cancer therapy. Experimental Biology and Medicine, 245(13), 1073\u20131086.","journal-title":"Experimental Biology and Medicine"},{"issue":"1","key":"11187_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40824-022-00296-0","volume":"26","author":"X Li","year":"2022","unstructured":"Li, X., Wang, H., Li, Z., Li, D., Lu, X., Ai, S., et al. (2022). Oxygen tank for synergistic hypoxia relief to enhance mitochondria-targeted photodynamic therapy. Biomaterials Research, 26(1), 47.","journal-title":"Biomaterials Research"},{"issue":"5","key":"11187_CR20","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/cancers13050986","volume":"13","author":"NS Aboelella","year":"2021","unstructured":"Aboelella, N. S., Brandle, C., Kim, T., Ding, Z-C., & Zhou, G. (2021). Oxidative stress in the tumor microenvironment and its relevance to cancer immunotherapy. Cancers, 13(5), 986.","journal-title":"Cancers"},{"issue":"12","key":"11187_CR21","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.7150\/thno.84500","volume":"13","author":"N Huang","year":"2023","unstructured":"Huang, N., Qian, A., Zou, Y., Lin, M., Pan, W., Chen, M., et al. (2023). Immunogenic radiation therapy for enhanced anti-tumor immunity via core-shell nanocomposite-mediated multiple strategies. Theranostics, 13(12), 4121.","journal-title":"Theranostics"},{"issue":"11","key":"11187_CR22","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1172\/JCI96268","volume":"128","author":"P Jayaprakash","year":"2018","unstructured":"Jayaprakash, P., Ai, M., Liu, A., Budhani, P., Bartkowiak, T., Sheng, J., et al. (2018). Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy. The Journal of clinical investigation, 128(11), 5137\u20135149.","journal-title":"The Journal of clinical investigation"},{"key":"11187_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1103149","volume":"13","author":"Z Zou","year":"2023","unstructured":"Zou, Z., Lin, H., Li, M., & Lin, B. (2023). Tumor\u2212 associated macrophage polarization in the inflammatory tumor microenvironment. Frontiers in Oncology, 13, Article 1103149.","journal-title":"Frontiers in Oncology"},{"key":"11187_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/aob-2025-1-51","volume":"11","author":"G Patidar","year":"2026","unstructured":"Patidar, G., Jose, A. V., Dubey, R., Huggins, M., Rafiee, B., Hershkop, M., et al. (2026). New developments and future trends of artificial blood. Annals of Blood, 11, 1.","journal-title":"Annals of Blood"},{"issue":"1","key":"11187_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40005-022-00590-y","volume":"53","author":"N Mohanto","year":"2023","unstructured":"Mohanto, N., Park, Y-J., & Jee, J-P. (2023). Current perspectives of artificial oxygen carriers as red blood cell substitutes: A review of old to cutting-edge technologies using in vitro and in vivo assessments. Journal of Pharmaceutical Investigation, 53(1), 153\u2013190.","journal-title":"Journal of Pharmaceutical Investigation"},{"issue":"5557","key":"11187_CR26","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1126\/science.1068443","volume":"295","author":"JE Squires","year":"2002","unstructured":"Squires, J. E. (2002). Artificial blood. Science, 295(5557), 1002\u20131005.","journal-title":"Science"},{"issue":"1S","key":"11187_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/SHK.0000000000001009","volume":"52","author":"AS Gupta","year":"2019","unstructured":"Gupta, A. S. (2019). Hemoglobin-based oxygen carriers: Current state-of-the-art and novel molecules. Shock, 52(1S), 70\u201383.","journal-title":"Shock"},{"key":"11187_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.1007960","volume":"10","author":"Z Yang","year":"2022","unstructured":"Yang, Z., Shi, C., Cheng, D., Wang, Y., Xing, Y., Du, F., et al. (2022). Biomimetic nanomaterial-facilitated oxygen generation strategies for enhancing tumour treatment outcomes. Frontiers in Bioengineering and Biotechnology, 10, Article 1007960.","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"2","key":"11187_CR29","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/ijms24021618","volume":"24","author":"S Hafeez","year":"2023","unstructured":"Hafeez, S., & Zaidi, N. U. S. S. (2023). Red blood cell substitutes: Liposome encapsulated hemoglobin and magnetite nanoparticle conjugates as oxygen carriers. International journal of molecular sciences, 24(2), 1618.","journal-title":"International journal of molecular sciences"},{"issue":"12","key":"11187_CR30","doi-asserted-by":"publisher","first-page":"7031","DOI":"10.1021\/acsbiomaterials.5c01322","volume":"11","author":"J Esmaeili","year":"2025","unstructured":"Esmaeili, J., & Jafari Aminabadi, R. (2025). Oxygen Delivery by Biopolymeric Scaffolds to Enhance Tissue Regeneration. ACS Biomaterials Science & Engineering, 11(12), 7031\u20137056.","journal-title":"ACS Biomaterials Science & Engineering"},{"issue":"1","key":"11187_CR31","first-page":"379","volume":"24","author":"J Williams","year":"2005","unstructured":"Williams, J. (2005). The use of marker-assisted selection in animal breeding and biotechnology. Revue scientifique et technique. (International Office of Epizootics), 24(1), 379\u2013391.","journal-title":"(International Office of Epizootics)"},{"issue":"1","key":"11187_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1600-0684.2010.00446.x","volume":"40","author":"T Schultheiss","year":"2011","unstructured":"Schultheiss, T., Stolte-Leeb, N., Sopper, S., & Stahl\u2010Hennig, C. (2011). Flow cytometric characterization of the lymphocyte composition in a variety of mucosal tissues in healthy rhesus macaques. Journal of Medical Primatology, 40(1), 41\u201351.","journal-title":"Journal of Medical Primatology"},{"key":"11187_CR33","doi-asserted-by":"publisher","first-page":"109692","DOI":"10.1016\/j.biopha.2019.109692","volume":"122","author":"L Lou","year":"2020","unstructured":"Lou, L., Tian, M., Chang, J., Li, F., & Zhang, G. (2020). MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7. Biomedicine & Pharmacotherapy, 122, 109692.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"7","key":"11187_CR34","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1021\/acs.molpharmaceut.3c00116","volume":"20","author":"Y Yang","year":"2023","unstructured":"Yang, Y., Liu, Y., & Jiang, Y. (2023). Recent advances in perfluorocarbon-based delivery systems for cancer theranostics. Molecular Pharmaceutics, 20(7), 3254\u20133277.","journal-title":"Molecular Pharmaceutics"},{"issue":"2","key":"11187_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00424-020-02482-2","volume":"473","author":"J J\u00e4gers","year":"2021","unstructured":"J\u00e4gers, J., Wrobeln, A., & Ferenz, K. B. (2021). Perfluorocarbon-based oxygen carriers: From physics to physiology. Pflugers Archiv. European Journal Of Physiology, 473(2), 139\u2013150. https:\/\/doi.org\/10.1007\/s00424-020-02482-2","journal-title":"Pflugers Archiv. European Journal Of Physiology"},{"issue":"6","key":"11187_CR36","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/10731190600973824","volume":"34","author":"JG Riess","year":"2006","unstructured":"Riess, J. G. (2006). Perfluorocarbon-based oxygen delivery. Artificial Cells, Blood Substitutes, And Immobilization Biotechnology, 34(6), 567\u2013580. https:\/\/doi.org\/10.1080\/10731190600973824","journal-title":"Artificial Cells, Blood Substitutes, And Immobilization Biotechnology"},{"issue":"6","key":"11187_CR37","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.ultrasmedbio.2021.01.032","volume":"47","author":"Q Lacerda","year":"2021","unstructured":"Lacerda, Q., Tantawi, M., Leeper, D. B., Wheatley, M. A., & Eisenbrey, J. R. (2021). Emerging applications of ultrasound-contrast agents in radiation therapy. Ultrasound in Medicine & Biology, 47(6), 1465\u201374. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2021.01.032","journal-title":"Ultrasound in Medicine & Biology"},{"issue":"9","key":"11187_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184250","volume":"12","author":"LA Feldman","year":"2017","unstructured":"Feldman, L. A., Fabre, M. S., Grasso, C., Reid, D., Broaddus, W. C., Lanza, G. M., et al. (2017). Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas. PLoS One, 12(9), Article e0184250. https:\/\/doi.org\/10.1371\/journal.pone.0184250","journal-title":"PLoS One"},{"key":"11187_CR39","doi-asserted-by":"publisher","first-page":"8785","DOI":"10.1038\/ncomms9785","volume":"6","author":"Y Cheng","year":"2015","unstructured":"Cheng, Y., Cheng, H., Jiang, C., Qiu, X., Wang, K., Huan, W., et al. (2015). Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy. Nature Communications, 6, 8785. https:\/\/doi.org\/10.1038\/ncomms9785","journal-title":"Nature Communications"},{"issue":"38","key":"11187_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202504725","volume":"12","author":"E Varga","year":"2025","unstructured":"Varga, E., Brandsma, E., Juarez-Garza, B. E., Ramlal, R. P. E., Karrich, J. J., Laurent, A., et al. (2025). Large-scale production of transfusion-ready red blood cells from induced pluripotent stem cells. Advanced Science, 12(38), Article e04725. https:\/\/doi.org\/10.1002\/advs.202504725","journal-title":"Advanced Science"},{"issue":"3","key":"11187_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/moh.0000000000000810","volume":"31","author":"N Gunawardena","year":"2024","unstructured":"Gunawardena, N., & Chou, S. T. (2024). Generation of red blood cells from induced pluripotent stem cells. Current Opinion In Hematology, 31(3), 115\u2013121. https:\/\/doi.org\/10.1097\/moh.0000000000000810","journal-title":"Current Opinion In Hematology"},{"issue":"10","key":"11187_CR42","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3324\/haematol.2010.023556","volume":"95","author":"H Lapillonne","year":"2010","unstructured":"Lapillonne, H., Kobari, L., Mazurier, C., Tropel, P., Giarratana, M. C., Zanella-Cleon, I., et al. (2010). Red blood cell generation from human induced pluripotent stem cells: Perspectives for transfusion medicine. Haematologica, 95(10), 1651\u20139. https:\/\/doi.org\/10.3324\/haematol.2010.023556","journal-title":"Haematologica"},{"key":"11187_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189808","author":"ZR Lim","year":"2021","unstructured":"Lim, Z. R., Vassilev, S., Leong, Y. W., Hang, J. W., R\u00e9nia, L., Malleret, B., et al. (2021). Industrially compatible transfusable iPSC-derived RBCs: Progress, challenges and prospective solutions. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms22189808","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"11187_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13287-024-03754-9","volume":"15","author":"H Ju","year":"2024","unstructured":"Ju, H., Sohn, Y., Nam, Y., & Rim, Y. A. (2024). Progresses in overcoming the limitations of in vitro erythropoiesis using human induced pluripotent stem cells. Stem Cell Research & Therapy, 15(1), 142. https:\/\/doi.org\/10.1186\/s13287-024-03754-9","journal-title":"Stem Cell Research & Therapy"},{"key":"11187_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cells12111554","author":"SJ Lee","year":"2023","unstructured":"Lee, S. J., Jung, C., Oh, J. E., Kim, S., Lee, S., Lee, J. Y., et al. (2023). Generation of red blood cells from human pluripotent stem cells-An update. Cells. https:\/\/doi.org\/10.3390\/cells12111554","journal-title":"Cells"},{"key":"11187_CR46","doi-asserted-by":"publisher","first-page":"1327466","DOI":"10.3389\/fcell.2023.1327466","volume":"11","author":"JH Jiang","year":"2023","unstructured":"Jiang, J. H., Ren, R. T., Cheng, Y. J., Li, X. X., & Zhang, G. R. (2023). Immune cells and RBCs derived from human induced pluripotent stem cells: Method, progress, prospective challenges. Front Cell Dev Biol, 11, 1327466. https:\/\/doi.org\/10.3389\/fcell.2023.1327466","journal-title":"Front Cell Dev Biol"},{"issue":"52","key":"11187_CR47","doi-asserted-by":"publisher","first-page":"33835","DOI":"10.1039\/d2ra06036a","volume":"12","author":"SA Salim","year":"2022","unstructured":"Salim, S. A., Salaheldin, T. A., Elmazar, M. M., Abdel-Aziz, A. F., & Kamoun, E. A. (2022). Smart biomaterials for enhancing cancer therapy by overcoming tumor hypoxia: A review. RSC Advances, 12(52), 33835\u201351. https:\/\/doi.org\/10.1039\/d2ra06036a","journal-title":"RSC Advances"},{"issue":"2","key":"11187_CR48","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3349\/ymj.2014.55.2.304","volume":"55","author":"HO Kim","year":"2014","unstructured":"Kim, H. O. (2014). In-vitro stem cell derived red blood cells for transfusion: Are we there yet? Yonsei Medical Journal, 55(2), 304\u2013309. https:\/\/doi.org\/10.3349\/ymj.2014.55.2.304","journal-title":"Yonsei Medical Journal"},{"issue":"1","key":"11187_CR49","doi-asserted-by":"publisher","DOI":"10.1097\/bs9.0000000000000215","volume":"7","author":"CG Chukwuemeka","year":"2025","unstructured":"Chukwuemeka, C. G., Ndubueze, C. W., Kolawole, A. V., Joseph, J. N., Oladipo, I. H., Ofoezie, E. F., et al. (2025). In vitro erythropoiesis: The emerging potential of induced pluripotent stem cells (iPSCs). Blood Science, 7(1), Article e00215. https:\/\/doi.org\/10.1097\/bs9.0000000000000215","journal-title":"Blood Science"},{"issue":"1","key":"11187_CR50","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41467-025-56239-5","volume":"16","author":"AP Shah","year":"2025","unstructured":"Shah, A. P., Majeti, K. R., Ekman, F. K., Selvaraj, S., Sharma, D., Sinha, R., et al. (2025). Engineering synthetic signaling receptors to enable erythropoietin-free erythropoiesis. Nature Communications, 16(1), 1140. https:\/\/doi.org\/10.1038\/s41467-025-56239-5","journal-title":"Nature Communications"},{"key":"11187_CR51","doi-asserted-by":"publisher","first-page":"100913","DOI":"10.1016\/j.mtbio.2023.100913","volume":"24","author":"J Ding","year":"2024","unstructured":"Ding, J., Ding, X., Liao, W., & Lu, Z. (2024). Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications. Mater Today Bio, 24, 100913. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100913","journal-title":"Mater Today Bio"},{"key":"11187_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2024.104167","volume":"131","author":"S Tur","year":"2024","unstructured":"Tur, S., Palii, C. G., & Brand, M. (2024). Cell fate decision in erythropoiesis: Insights from multiomics studies. Experimental Hematology, 131, Article 104167.","journal-title":"Experimental Hematology"},{"issue":"2","key":"11187_CR53","doi-asserted-by":"publisher","first-page":"nwaa160","DOI":"10.1093\/nsr\/nwaa160","volume":"8","author":"MZ Zou","year":"2021","unstructured":"Zou, M. Z., Liu, W. L., Chen, H. S., Bai, X. F., Gao, F., Ye, J. J., et al. (2021). Advances in nanomaterials for treatment of hypoxic tumor. Natl Sci Rev, 8(2), nwaa160. https:\/\/doi.org\/10.1093\/nsr\/nwaa160","journal-title":"Natl Sci Rev"},{"issue":"4","key":"11187_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/nano16040225","volume":"16","author":"SM V\u00edafara-Garc\u00eda","year":"2026","unstructured":"V\u00edafara-Garc\u00eda, S. M., Torres, G., Chac\u00f3n, C., Palma, J. L., Rojas-Nunez, J., Landaeta, E., et al. (2026). Nanobubble-mediated oxygen delivery mitigates hypoxia-induced ROS and HIF-1\u03b1 expression in UC-MSCs. Nanomaterials, 16(4), Article 225.","journal-title":"Nanomaterials"},{"issue":"2","key":"11187_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwaa160","volume":"8","author":"M-Z Zou","year":"2021","unstructured":"Zou, M.-Z., Liu, W.-L., Chen, H.-S., Bai, X.-F., Gao, F., Ye, J.-J., et al. (2021). Advances in nanomaterials for treatment of hypoxic tumor. National Science Review, 8(2), Article nwaa160.","journal-title":"National Science Review"},{"key":"11187_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100687","volume":"20","author":"Y He","year":"2023","unstructured":"He, Y., Chang, Q., & Lu, F. (2023). Oxygen-releasing biomaterials for chronic wounds breathing: From theoretical mechanism to application prospect. Materials Today Bio, 20, Article 100687.","journal-title":"Materials Today Bio"},{"key":"11187_CR57","doi-asserted-by":"publisher","unstructured":"Han, X., Saengow, C., Ju, L., Ren, W., Ewoldt, R. H., & Irudayaraj, J. (2024). Exosome-coated oxygen nanobubble-laden hydrogel augments intracellular delivery of exosomes for enhanced wound healing. Nature Communications, 15(1), 3435. https:\/\/doi.org\/10.1038\/s41467-024-47696-5","DOI":"10.1038\/s41467-024-47696-5"},{"issue":"27","key":"11187_CR58","doi-asserted-by":"publisher","first-page":"10980","DOI":"10.1073\/pnas.1106634108","volume":"108","author":"C-M Hu","year":"2011","unstructured":"Hu, C.-M., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011). Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proceedings of the National Academy of Sciences of the United States of America, 108(27), 10980\u20135.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"11187_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.683519","volume":"8","author":"X Li","year":"2021","unstructured":"Li, X., Wu, Y., Zhang, R., Bai, W., Ye, T., & Wang, S. (2021). Oxygen-based nanocarriers to modulate tumor hypoxia for ameliorated anti-tumor therapy: Fabrications, properties, and future directions. Frontiers in Molecular Biosciences, 8, Article 683519.","journal-title":"Frontiers in Molecular Biosciences"},{"key":"11187_CR60","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s521444","author":"Y Wang","year":"2025","unstructured":"Wang, Y., Li, T., Zhou, H., & Liu, C. (2025). Advancements in nanocarrier delivery systems for photodynamic therapy in lung cancer. International Journal of Nanomedicine.2025;20:6853\u20136874 https:\/\/doi.org\/10.2147\/ijn.s521444","journal-title":"International Journal of Nanomedicine"},{"issue":"10","key":"11187_CR61","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3390\/cancers11101464","volume":"11","author":"MS Khan","year":"2019","unstructured":"Khan, M. S., Hwang, J., Lee, K., Choi, Y., Seo, Y., Jeon, H., et al. (2019). Anti-tumor drug-loaded oxygen nanobubbles for the degradation of HIF-1\u03b1 and the upregulation of reactive oxygen species in tumor cells. Cancers, 11(10), 1464.","journal-title":"Cancers"},{"issue":"2","key":"11187_CR62","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/medicina59020396","volume":"59","author":"L Chen","year":"2023","unstructured":"Chen, L., Yang, Z., & Liu, H. (2023). Hemoglobin-based oxygen carriers: Where are we now in 2023? Medicina, 59(2), 396.","journal-title":"Medicina"},{"issue":"5","key":"11187_CR63","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1021\/acs.bioconjchem.8b00093","volume":"29","author":"F Meng","year":"2018","unstructured":"Meng, F., Kassa, T., Jana, S., Wood, F., Zhang, X., Jia, Y., et al. (2018). Comprehensive biochemical and biophysical characterization of hemoglobin-based oxygen carrier therapeutics: All HBOCs are not created equally. Bioconjugate Chemistry, 29(5), 1560\u201375.","journal-title":"Bioconjugate Chemistry"},{"key":"11187_CR64","doi-asserted-by":"crossref","unstructured":"Cheng, Y., Cheng, H., Jiang, C., Qiu, X., Wang, K., Huan, W., et al. (2015). Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy. Nature Communications, 6(1), 8785. https:\/\/doi.org\/10.1038\/ncomms9785","DOI":"10.1038\/ncomms9785"},{"issue":"1","key":"11187_CR65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jatmed.2024.02.003","volume":"3","author":"M Zhao","year":"2024","unstructured":"Zhao, M., Liu, H., & Jahr, J. S. (2024). Perfluorocarbon-based oxygen carriers: What is new in 2024? Journal of Anesthesia and Translational Medicine, 3(1), 10\u201313.","journal-title":"Journal of Anesthesia and Translational Medicine"},{"key":"11187_CR66","doi-asserted-by":"crossref","unstructured":"Sugimoto, N., Kanda, J., Nakamura, S., Kitano, T., Hishizawa, M., Kondo, T., et al. (2022). iPLAT1: The first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study. Blood, The Journal of the American Society of Hematology 140(22), 2398\u2013402.","DOI":"10.1182\/blood.2022017296"},{"issue":"31","key":"11187_CR67","doi-asserted-by":"publisher","first-page":"10166","DOI":"10.1021\/acs.langmuir.8b03650","volume":"35","author":"R Song","year":"2019","unstructured":"Song, R., Peng, S., Lin, Q., Luo, M., Chung, H. Y., Zhang, Y., et al. (2019). pH-responsive oxygen nanobubbles for spontaneous oxygen delivery in hypoxic tumors. Langmuir, 35(31), 10166\u201372. https:\/\/doi.org\/10.1021\/acs.langmuir.8b03650","journal-title":"Langmuir"},{"issue":"3","key":"11187_CR68","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41590-020-00860-7","volume":"22","author":"JH Park","year":"2021","unstructured":"Park, J. H., Kim, H-J., Kim, C. W., Kim, H. C., Jung, Y., Lee, H-S., et al. (2021). Tumor hypoxia represses \u03b3\u03b4 T cell-mediated antitumor immunity against brain tumors. Nature immunology, 22(3), 336\u2013346.","journal-title":"Nature immunology"},{"issue":"24","key":"11187_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413346","volume":"22","author":"Z-X Liao","year":"2021","unstructured":"Liao, Z.-X., Ou, D.-L., Hsieh, M.-J., & Hsieh, C.-C. (2021). Synergistic effect of repolarization of M2 to M1 macrophages induced by iron oxide nanoparticles combined with lactate oxidase. International Journal of Molecular Sciences, 22(24), Article 13346.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"11187_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46210-1","volume":"15","author":"Y Xue","year":"2024","unstructured":"Xue, Y., Yan, X., Li, D., Dong, S., & Ping, Y. (2024). Proinflammatory polarization of engineered heat-inducible macrophages reprogram the tumor immune microenvironment during cancer immunotherapy. Nature Communications, 15(1), Article 2270.","journal-title":"Nature Communications"},{"key":"11187_CR71","first-page":"46","volume":"8","author":"X Cheng","year":"2025","unstructured":"Cheng, X., Wang, P., Lyu, H., Lee, Y., Yoon, J., & Dong, H. (2025). Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistance. Cancer Drug Resistance, 8, 46.","journal-title":"Cancer Drug Resistance"},{"issue":"11","key":"11187_CR72","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1021\/acs.molpharmaceut.9b00663","volume":"16","author":"M-S Jiang","year":"2019","unstructured":"Jiang, M-S., Yin, X-Y., Qin, B., Xuan, S-Y., Yuan, X-L., Yin, H., et al. (2019). Inhibiting hypoxia and chemotherapy-induced cancer cell metastasis under a valid therapeutic effect by an assistance of biomimetic oxygen delivery. Molecular Pharmaceutics, 16(11), 4530\u20134541.","journal-title":"Molecular Pharmaceutics"},{"issue":"5","key":"11187_CR73","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1039\/D4NA00924J","volume":"7","author":"J Zheng","year":"2025","unstructured":"Zheng, J., Peng, W., Shi, H., Zhang, J., Hu, Q., & Chen, J. (2025). Emerging engineered nanozymes: Current status and future perspectives in cancer treatments. Nanoscale Advances, 7(5), 1226\u20131242.","journal-title":"Nanoscale Advances"},{"key":"11187_CR74","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bioactmat.2024.04.008","volume":"38","author":"Y Pan","year":"2024","unstructured":"Pan, Y., Yu, L., Liu, L., Zhang, J., Liang, S., Parshad, B., et al. (2024). Genetically engineered nanomodulators elicit potent immunity against cancer stem cells by checkpoint blockade and hypoxia relief. Bioactive Materials, 38, 31\u201344.","journal-title":"Bioactive Materials"},{"issue":"18","key":"11187_CR75","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.7150\/thno.27598","volume":"8","author":"Z Zhou","year":"2018","unstructured":"Zhou, Z., Zhang, B., Wang, H., Yuan, A., Hu, Y., & Wu, J. (2018). Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles. Theranostics, 8(18), 4898.","journal-title":"Theranostics"},{"issue":"11","key":"11187_CR76","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.tibtech.2021.01.007","volume":"39","author":"NG Willemen","year":"2021","unstructured":"Willemen, N. G., Hassan, S., Gurian, M., Li, J., Allijn, I. E., Shin, S. R., et al. (2021). Oxygen-releasing biomaterials: Current challenges and future applications. Trends in Biotechnology, 39(11), 1144\u201359.","journal-title":"Trends in Biotechnology"},{"key":"11187_CR77","doi-asserted-by":"crossref","unstructured":"Xiang, S., Zhang, H., Zhang, J., Li, X., Lin, X., & Sun, W. (2025). Breaking hypoxic barrier: Oxygen-supplied nanomaterials for enhanced T cell-mediated tumor immunotherapy. International Journal of Pharmaceutics: X, 10, 100400.","DOI":"10.1016\/j.ijpx.2025.100400"},{"issue":"38","key":"11187_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202502807","volume":"35","author":"Z Chen","year":"2025","unstructured":"Chen, Z., He, Q., Qian, R., Cai, J., Wang, Z., Zhou, X., et al. (2025). Reengineering the tumor oxygen microenvironment in radiotherapy to enhance T-cell function for radio-immunotherapy. Advanced Functional Materials, 35(38), Article 2502807.","journal-title":"Advanced Functional Materials"},{"key":"11187_CR79","doi-asserted-by":"publisher","first-page":"118543","DOI":"10.1016\/j.biopha.2025.118543","volume":"191","author":"V Ghassemifar","year":"2025","unstructured":"Ghassemifar, V., Zahedi, A., Meigoli, M. S. S., Mokhtari, T., Zadeh, S. S. M., Parsafar, M., et al. (2025). Harnessing nanotechnology to modulate hypoxic tumor microenvironments: Enhanced strategies for oncological innovations. Biomedicine & Pharmacotherapy, 191, 118543.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"11187_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2026.124320","author":"Y Pan","year":"2026","unstructured":"Pan, Y., Tang, Y., Chen, L., Xu, Y., Hu, X., Zhang, J., et al. (2026). Modularly designed hybrid vesicles as dual-adjuvant nanovaccines for cancer immunotherapy. Biomaterials, 335, 124320. https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124320","journal-title":"Biomaterials"},{"issue":"13","key":"11187_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202400068","volume":"13","author":"Y Pan","year":"2024","unstructured":"Pan, Y., Wu, X., Liu, L., Zhao, C., Zhang, J., Yang, S., et al. (2024). Genetically engineered cytomembrane nanovaccines for cancer immunotherapy. Advanced Healthcare Materials, 13(13), Article 2400068.","journal-title":"Advanced Healthcare Materials"},{"issue":"1","key":"11187_CR82","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12951-022-01316-w","volume":"20","author":"R Gao","year":"2022","unstructured":"Gao, R., Gu, Y., Yang, Y., He, Y., Huang, W., Sun, T., et al. (2022). Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma. J Nanobiotechnology, 20(1), 115. https:\/\/doi.org\/10.1186\/s12951-022-01316-w","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"11187_CR83","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jatmed.2024.02.003","volume":"3","author":"M Zhao","year":"2024","unstructured":"Zhao, M., Liu, H., & Jahr, J. S. (2024). Perfluorocarbon-based oxygen carriers: What is new in 2024? Journal of Anesthesia & Translational Medicine, 3(1), 10\u20133. https:\/\/doi.org\/10.1016\/j.jatmed.2024.02.003","journal-title":"Journal of Anesthesia & Translational Medicine"},{"key":"11187_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23092210","author":"MS Khan","year":"2018","unstructured":"Khan, M. S., Hwang, J., Lee, K., Choi, Y., Kim, K., Koo, H. J., et al. (2018). Oxygen-carrying micro\/nanobubbles: Composition, synthesis techniques and potential prospects in photo-triggered theranostics. Molecules, 23(9), 2210. https:\/\/doi.org\/10.3390\/molecules23092210","journal-title":"Molecules"},{"key":"11187_CR85","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jcrc.2018.04.008","volume":"51","author":"F Marrazzo","year":"2019","unstructured":"Marrazzo, F., Larson, G., Sherpa Lama, T. T., Teggia Droghi, M., Joyce, M., Ichinose, F., et al. (2019). Inhaled nitric oxide prevents systemic and pulmonary vasoconstriction due to hemoglobin-based oxygen carrier infusion: A case report. Journal of Critical Care, 51, 213\u20136. https:\/\/doi.org\/10.1016\/j.jcrc.2018.04.008","journal-title":"Journal of Critical Care"},{"key":"11187_CR86","doi-asserted-by":"publisher","first-page":"100927","DOI":"10.1016\/j.blre.2022.100927","volume":"54","author":"NB Charbe","year":"2022","unstructured":"Charbe, N. B., Castillo, F., Tambuwala, M. M., Prasher, P., Chellappan, D. K., Carre\u00f1o, A., et al. (2022). A new era in oxygen therapeutics? From perfluorocarbon systems to haemoglobin-based oxygen carriers. Blood Reviews, 54, 100927. https:\/\/doi.org\/10.1016\/j.blre.2022.100927","journal-title":"Blood Reviews"},{"issue":"7","key":"11187_CR87","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2217\/rme-2018-0095","volume":"13","author":"S Sullivan","year":"2018","unstructured":"Sullivan, S., Stacey, G. N., Akazawa, C., Aoyama, N., Baptista, R., Bedford, P., et al. (2018). Quality control guidelines for clinical-grade human induced pluripotent stem cell lines. Regenerative Medicine, 13(7), 859\u201366. https:\/\/doi.org\/10.2217\/rme-2018-0095","journal-title":"Regenerative Medicine"},{"key":"11187_CR88","doi-asserted-by":"publisher","first-page":"683519","DOI":"10.3389\/fmolb.2021.683519","volume":"8","author":"X Li","year":"2021","unstructured":"Li, X., Wu, Y., Zhang, R., Bai, W., Ye, T., & Wang, S. (2021). Oxygen-Based Nanocarriers to Modulate Tumor Hypoxia for Ameliorated Anti-Tumor Therapy: Fabrications, Properties, and Future Directions. Front Mol Biosci, 8, 683519. https:\/\/doi.org\/10.3389\/fmolb.2021.683519","journal-title":"Front Mol Biosci"},{"issue":"9","key":"11187_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2023.03.040","volume":"54","author":"CF Mackenzie","year":"2023","unstructured":"Mackenzie, C. F., Dub\u00e9, G. P., & Pitman, A. N. (2023). Re-analysis of the PolyHeme phase III trial dataset: Lessons for future haemoglobin-based oxygen carrier trauma trials. Injury, 54(9), Article 110712. https:\/\/doi.org\/10.1016\/j.injury.2023.03.040","journal-title":"Injury"},{"issue":"10","key":"11187_CR90","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1111\/trf.13726","volume":"56","author":"M Mer","year":"2016","unstructured":"Mer, M., Hodgson, E., Wallis, L., Jacobson, B., Levien, L., Snyman, J., et al. (2016). Hemoglobin glutamer-250 (bovine) in South Africa: Consensus usage guidelines from clinician experts who have treated patients. Transfusion, 56(10), 2631\u20132636. https:\/\/doi.org\/10.1111\/trf.13726","journal-title":"Transfusion"},{"issue":"3","key":"11187_CR91","doi-asserted-by":"publisher","first-page":"e1776","DOI":"10.1002\/wnan.1776","volume":"14","author":"S Malhotra","year":"2022","unstructured":"Malhotra, S., Dumoga, S., & Singh, N. (2022). Red blood cells membrane-derived nanoparticles: Applications and key challenges in their clinical translation. Wiley Interdisciplinary Reviews. Nanomedicine And Nanobiotechnology, 14(3), e1776. https:\/\/doi.org\/10.1002\/wnan.1776","journal-title":"Wiley Interdisciplinary Reviews. Nanomedicine And Nanobiotechnology"},{"issue":"Pt 1","key":"11187_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.144587","volume":"317","author":"Z Ghasemi","year":"2025","unstructured":"Ghasemi, Z., Maleki, A., Jafari, T., & Naghib, S. M. (2025). A review of multimodule stimuli-responsive chitosan-incorporated lipid-based micro\/nanocarriers for drug delivery in cancer therapy: Promises, outlooks, and prospects. International Journal of Biological Macromolecules, 317(Pt 1), Article 144587. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144587","journal-title":"International Journal of Biological Macromolecules"},{"key":"11187_CR93","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jconrel.2022.12.009","volume":"353","author":"M Shahpouri","year":"2023","unstructured":"Shahpouri, M., Adili-Aghdam, M. A., Mahmudi, H., Jaymand, M., Amoozgar, Z., Akbari, M., et al. (2023). Prospects for hypoxia-based drug delivery platforms for the elimination of advanced metastatic tumors: From 3D modeling to clinical concepts. Journal of Controlled Release, 353, 1002\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.009","journal-title":"Journal of Controlled Release"},{"key":"11187_CR94","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.2147\/ijn.S173914","volume":"13","author":"J Li","year":"2018","unstructured":"Li, J., Shang, W., Li, Y., Fu, S., Tian, J., & Lu, L. (2018). Advanced nanomaterials targeting hypoxia to enhance radiotherapy. Int J Nanomedicine, 13, 5925\u20135936. https:\/\/doi.org\/10.2147\/ijn.S173914","journal-title":"Int J Nanomedicine"},{"key":"11187_CR95","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.2147\/ijn.S140462","volume":"13","author":"K Graham","year":"2018","unstructured":"Graham, K., & Unger, E. (2018). Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment. International Journal of Nanomedicine, 13, 6049\u201358. https:\/\/doi.org\/10.2147\/ijn.S140462","journal-title":"International Journal of Nanomedicine"},{"key":"11187_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091763","author":"Y Du","year":"2022","unstructured":"Du, Y., Han, J., Jin, F., & Du, Y. (2022). Recent strategies to address hypoxic tumor environments in photodynamic therapy. Pharmaceutics, 14(9), 1763. https:\/\/doi.org\/10.3390\/pharmaceutics14091763","journal-title":"Pharmaceutics"},{"issue":"1","key":"11187_CR97","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12951-024-02606-1","volume":"22","author":"K Zhu","year":"2024","unstructured":"Zhu, K., Wang, L., Xiao, Y., Zhang, X., You, G., Chen, Y., et al. (2024). Nanomaterial-related hemoglobin-based oxygen carriers, with emphasis on liposome and nano-capsules, for biomedical applications: Current status and future perspectives. J Nanobiotechnology, 22(1), 336. https:\/\/doi.org\/10.1186\/s12951-024-02606-1","journal-title":"J Nanobiotechnology"},{"key":"11187_CR98","doi-asserted-by":"publisher","first-page":"0355","DOI":"10.34133\/bmr.0355","volume":"30","author":"J Oh","year":"2026","unstructured":"Oh, J., Cho, H., Kim, K., Park, Y. J., Huh, Y. S., & Son, S. (2026). Oxygen Permeable Dextran Nanogels as a Hemoglobin-Based Oxygen Carrier. Biomater Res, 30, 0355. https:\/\/doi.org\/10.34133\/bmr.0355","journal-title":"Biomater Res"},{"key":"11187_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/ph17101389","author":"SK Debnath","year":"2024","unstructured":"Debnath, S. K., Debnath, M., Ghosh, A., Srivastava, R., & Omri, A. (2024). Targeting tumor hypoxia with nanoparticle-based therapies: Challenges, opportunities, and clinical implications. Pharmaceuticals, 17(5), 633. https:\/\/doi.org\/10.3390\/ph17101389","journal-title":"Pharmaceuticals"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11187-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:03:41Z","timestamp":1788768221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-026-11187-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":99,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11187"],"URL":"https:\/\/doi.org\/10.1007\/s12015-026-11187-5","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial no","group":{"name":"EthicsHeading","label":"Declarations"}}]}}